单倍体造血干细胞移植联合泊马度胺后的 NK 细胞命运。
NK cell destiny after haploSCT with PT-Cy.
机构信息
Hadassah University Hospital.
Tel Aviv University.
出版信息
Blood. 2018 Jan 11;131(2):161-162. doi: 10.1182/blood-2017-10-811117.
Abstract
In this issue of , Russo et al provide important insights on the effect of posttransplantation cyclophosphamide (PT-Cy) on natural killer (NK) cell recovery and function after haploidentical allogeneic stem cell transplantation (haploSCT).
摘要
本期《 》中，Russo 等人就移植后环磷酰胺（PT-Cy）对单倍体相合异基因干细胞移植（haploSCT）后自然杀伤（NK）细胞恢复和功能的影响提供了重要见解。
相似文献
1
NK cell destiny after haploSCT with PT-Cy.单倍体造血干细胞移植联合泊马度胺后的 NK 细胞命运。
Blood. 2018 Jan 11;131(2):161-162. doi: 10.1182/blood-2017-10-811117.
2
NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications.亲缘半相合造血干细胞移植后应用环磷酰胺后 NK 细胞的恢复：动力学及其临床意义。
Blood. 2018 Jan 11;131(2):247-262. doi: 10.1182/blood-2017-05-780668. Epub 2017 Oct 6.
3
A prospective observational study of immune reconstitution following transplantation with post-transplant reduced-dose cyclophosphamide from HLA-haploidentical donors.HLA 单倍体相合供者移植后接受低剂量环磷酰胺的免疫重建前瞻性观察研究。
Transpl Int. 2019 Dec;32(12):1322-1332. doi: 10.1111/tri.13494. Epub 2019 Sep 9.
4
[Application of low dose of fludarabine and cyclophosphamide combined with donor NK Cells as a non-myeloablative conditioning regimen for the haploidentical hematopoietic stem cell transplantation in mice].[低剂量氟达拉滨和环磷酰胺联合供体自然杀伤细胞作为非清髓性预处理方案在小鼠单倍体造血干细胞移植中的应用]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Oct;15(5):1013-8.
5
Early Cytomegalovirus Reactivation and Expansion of CD56CD16DNAM1 Natural Killer Cells Are Associated with Antileukemia Effect after Haploidentical Stem Cell Transplantation in Acute Leukemia.早期巨细胞病毒再激活和 CD56CD16DNAM1 自然杀伤细胞的扩增与急性白血病患者接受单倍体造血干细胞移植后的抗白血病效应有关。
Biol Blood Marrow Transplant. 2019 Oct;25(10):2070-2078. doi: 10.1016/j.bbmt.2019.06.008. Epub 2019 Jun 15.
6
Pediatric unmanipulated haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide and reduced intensity, TBI-free conditioning regimens in salvage transplantations.儿童未处理的单倍体相合造血干细胞移植联合移植后环磷酰胺及低强度、无全身照射预处理方案用于挽救性移植。
Adv Clin Exp Med. 2019 Sep;28(9):1223-1228. doi: 10.17219/acem/104688.
7
Cardiomyopathy in patients after posttransplant cyclophosphamide-based hematopoietic cell transplantation.基于环磷酰胺的造血细胞移植后患者的心肌病
Cancer. 2017 May 15;123(10):1800-1809. doi: 10.1002/cncr.30534. Epub 2017 Mar 6.
8
Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT.针对急性白血病患者，在接受 HLA 匹配的同胞或无关供体移植时，使用移植后环磷酰胺预防移植物抗宿主病：代表 ALWP-EBMT。
J Hematol Oncol. 2018 Mar 15;11(1):40. doi: 10.1186/s13045-018-0586-4.
9
Combination chemo-immunotherapy: kinetics of in vivo and in vitro generation of natural killer cells and lymphokine-activated killer cells in the rat.联合化学免疫疗法：大鼠体内及体外自然杀伤细胞和淋巴因子激活的杀伤细胞生成的动力学
Clin Exp Immunol. 1990 Mar;79(3):416-23. doi: 10.1111/j.1365-2249.1990.tb08105.x.
10
Phase II Study of Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Myeloid Malignancies Following Allogeneic Hematopoietic Cell Transplantation.单倍体相合自然杀伤细胞输注治疗异基因造血细胞移植后复发或持续性髓系恶性肿瘤的II期研究
Biol Blood Marrow Transplant. 2016 Apr;22(4):705-709. doi: 10.1016/j.bbmt.2015.12.028. Epub 2016 Jan 6.
本文引用的文献
1
NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications.亲缘半相合造血干细胞移植后应用环磷酰胺后 NK 细胞的恢复：动力学及其临床意义。
Blood. 2018 Jan 11;131(2):247-262. doi: 10.1182/blood-2017-05-780668. Epub 2017 Oct 6.
2
Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.单倍体造血细胞移植治疗成人急性髓系白血病：欧洲血液和骨髓移植学会急性白血病工作组的立场声明。
Haematologica. 2017 Nov;102(11):1810-1822. doi: 10.3324/haematol.2017.176107. Epub 2017 Sep 7.
3
A review of infectious complications after haploidentical hematopoietic stem cell transplantations.单倍型相合造血干细胞移植后感染性并发症的综述
Infection. 2017 Aug;45(4):403-411. doi: 10.1007/s15010-017-1016-1. Epub 2017 Apr 17.
4
Overview of the progress on haploidentical hematopoietic transplantation.单倍体相合造血移植的进展概述
World J Transplant. 2016 Dec 24;6(4):665-674. doi: 10.5500/wjt.v6.i4.665.
5
Haploidentical hematopoietic transplantation for the cure of leukemia: from its biology to clinical translation.单倍体相合造血移植治疗白血病：从生物学基础到临床转化。
Blood. 2016 Dec 8;128(23):2616-2623. doi: 10.1182/blood-2016-07-730564. Epub 2016 Oct 3.
6
Infections after T-replete haploidentical transplantation and high-dose cyclophosphamide as graft-versus-host disease prophylaxis.全相合单倍体移植及大剂量环磷酰胺预防移植物抗宿主病后的感染
Transpl Infect Dis. 2015 Apr;17(2):242-9. doi: 10.1111/tid.12365.
7
Cellular and molecular basis of haploidentical hematopoietic stem cell transplantation in the successful treatment of high-risk leukemias: role of alloreactive NK cells.同种异体造血干细胞移植成功治疗高危白血病的细胞和分子基础：同种反应性 NK 细胞的作用。
Front Immunol. 2013 Feb 1;4:15. doi: 10.3389/fimmu.2013.00015. eCollection 2013.
8
Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts.非血缘供者移植后经减低强度预处理：使用部分 HLA 错配相关骨髓或无关双脐血移植物的平行 2 期试验结果。
Blood. 2011 Jul 14;118(2):282-8. doi: 10.1182/blood-2011-03-344853. Epub 2011 Apr 28.
9
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value.急性髓系白血病单倍体相合造血移植中供体自然杀伤细胞对缺失自我的同种异体识别：对其预测价值提出挑战
Blood. 2007 Jul 1;110(1):433-40. doi: 10.1182/blood-2006-07-038687. Epub 2007 Mar 19.
10
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer.人类单倍体相合自然杀伤细胞在癌症患者中的成功过继转移及体内扩增。
Blood. 2005 Apr 15;105(8):3051-7. doi: 10.1182/blood-2004-07-2974. Epub 2005 Jan 4.
Zotero 插件